Physician profile
Theodore Chen
NPI 1710187802
$480.06
in general payments reported to CMS, 2019-2025
9 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $33.17 · 2022: $18.06 · 2023: $74.58 · 2024: $67.26 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $181.92 | 2024-2025 | Inspire |
| Stryker Corporation | $67.39 | 2019 | |
| Smith+Nephew, INC. | $54.60 | 2023-2025 | Tula, Ent Sinus, Rf20000 |
| Medtronic USA, INC. | $51.70 | 2019-2020 | |
| Medtronic, INC. | $46.35 | 2023 | Propel |
| Abiomed | $27.83 | 2024 | Impella |
| Aerin Medical INC. | $18.06 | 2022 | |
| Intersect Ent, INC. | $17.28 | 2019 | |
| Boston Scientific Corporation | $14.93 | 2024 | Wavewriter Alpha Prime 16 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.